Role of Phospho-ezrin in Differentiating Thyroid Carcinoma

Overview

Journal Sci Rep

Specialty Science

Date 2019 Apr 19

PMID 30996241

Citations 5

Authors

Lakshmi Mohan Lathika

Jagathnath Krishna Kumarapillai Mohanan Nair

Valliamma Neelakandapilla Saritha

Kunjuraman Sujathan

Sreeharshan Sreeja

Affiliations

Soon will be listed here.

Abstract

Comprehensive theory explaining the relationship between estrogen (E2) and ezrin in metastasis of thyroid cancer remains non-elicited. In vitro results revealed that E2 could stimulate the expression and phosphorylation of ezrin in a time and dose dependent manner. Our data clearly showed that E2 enhanced the migration and invasion of cells, which was reversed by the transfection of cells with ezrin specific siRNA. Further, we observed that Phosphoinositide 3-kinase (PI3K) ROCK-2 are among the kinases responsible for E2 induced phosphorylation of ezrin. Clinical validation of ezrin/phospho-ezrin revealed that phospho-ezrin was intensely expressed in follicular thyroid carcinoma (FTC) and follicular variant of papillary thyroid carcinoma (FVPTC), while it was completely absent in follicular adenoma (FA) lesions in which the differentiation of the follicular neoplasms remains subtle. When histology of different carcinomas is correlated with benign FA with respect to phospho-ezrin, we observed that the marker was highly significant (p = 0.0001). 100% sensitivity, specificity and diagnostic accuracy of the above marker in the histological association of FTC, FVPTC with FA, enables us to suggest phospho-ezrin as a diagnostic marker to differentiate the follicular neoplasms. These data are the first to suggest the dynamic regulation of ezrin phosphorylation during metastasis in FTC.

Citing Articles

Histone H3K18 and Ezrin Lactylation Promote Renal Dysfunction in Sepsis-Associated Acute Kidney Injury.

Qiao J, Tan Y, Liu H, Yang B, Zhang Q, Liu Q Adv Sci (Weinh). 2024; 11(28):e2307216.

PMID: 38767134 PMC: 11267308. DOI: 10.1002/advs.202307216.

The Changing Face of Culture Models for Thyroid Cancer Research: A Systematic Literature Review.

Chew D, Green V, Riley A, England R, Greenman J Front Surg. 2020; 7:43.

PMID: 32766274 PMC: 7378741. DOI: 10.3389/fsurg.2020.00043.

Knockdown of Ezrin inhibited migration and invasion of cervical cancer cells in vitro.

Xi M, Tang W Int J Immunopathol Pharmacol. 2020; 34:2058738420930899.

PMID: 32674647 PMC: 7370327. DOI: 10.1177/2058738420930899.

Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells.

Du S, Song X, Li Y, Cao Y, Chu F, Durojaye O Sci Rep. 2020; 10(1):11273.

PMID: 32647287 PMC: 7347585. DOI: 10.1038/s41598-020-68238-1.

Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming.

Wang X, Li N, Han A, Wang Y, Lin Z, Yang Y Cancer Sci. 2020; 111(11):4061-4074.

PMID: 32639665 PMC: 7648033. DOI: 10.1111/cas.14562.

References

Song R, McPherson R, Adam L, Bao Y, Shupnik M, Kumar R . Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol Endocrinol. 2002; 16(1):116-27. DOI: 10.1210/mend.16.1.0748. View

Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M . Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab. 2001; 86(3):1072-7. DOI: 10.1210/jcem.86.3.7283. View

Benedict M, Costa J . Metastatic Papillary Thyroid Carcinoma with Multifocal Synchronous Transformation to Anaplastic Thyroid Carcinoma. Case Rep Pathol. 2016; 2016:4863405. PMC: 5059640. DOI: 10.1155/2016/4863405. View

Song J, Fadiel A, Edusa V, Chen Z, So J, Sakamoto H . Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen. Cancer Lett. 2005; 220(1):57-65. DOI: 10.1016/j.canlet.2004.04.024. View

Yoon J, Kwak J, Kim E, Moon H, Kim M, Kim J . How to approach thyroid nodules with indeterminate cytology. Ann Surg Oncol. 2010; 17(8):2147-55. DOI: 10.1245/s10434-010-0992-5. View

Chambliss K, Wu Q, Oltmann S, Konaniah E, Umetani M, Korach K . Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest. 2010; 120(7):2319-30. PMC: 2898582. DOI: 10.1172/JCI38291. View

Yu Y, Khan J, Khanna C, Helman L, Meltzer P, Merlino G . Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004; 10(2):175-81. DOI: 10.1038/nm966. View

Smith J, Cheifetz R, Schneidereit N, Berean K, Thomson T . Can cytology accurately predict benign follicular nodules?. Am J Surg. 2005; 189(5):592-5. DOI: 10.1016/j.amjsurg.2005.01.028. View

Sanchez A, Flamini M, Zullino S, Gopal S, Genazzani A, Simoncini T . Estrogen receptor-{alpha} promotes endothelial cell motility through focal adhesion kinase. Mol Hum Reprod. 2010; 17(4):219-26. DOI: 10.1093/molehr/gaq097. View

10.

Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C . Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 2001; 61(9):3750-9. View

11.

Hima S, Sreeja S . Regulatory role of estrogen-induced reactive oxygen species in the modulatory function of UCP 2 in papillary thyroid cancer cells. IUBMB Life. 2015; 67(11):837-46. DOI: 10.1002/iub.1440. View

12.

Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y . Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett. 2007; 261(1):55-63. DOI: 10.1016/j.canlet.2007.11.018. View

13.

Davies L, Welch H . Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295(18):2164-7. DOI: 10.1001/jama.295.18.2164. View

14.

Huang Y, Dong W, Li J, Zhang H, Shan Z, Teng W . Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma. BMC Cancer. 2014; 14:383. PMC: 4049482. DOI: 10.1186/1471-2407-14-383. View

15.

Zheng S, Huang J, Zhou K, Zhang C, Xiang Q, Tan Z . 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin. PLoS One. 2011; 6(7):e22439. PMC: 3144228. DOI: 10.1371/journal.pone.0022439. View

16.

Wang H, Zhu J, Zhang Q, Sun Q, Guo H . High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy. World J Gastroenterol. 2009; 15(16):2016-9. PMC: 2675094. DOI: 10.3748/wjg.15.2016. View

17.

Fadiel A, Choi S, Park B, Kim T, Buldo-Licciardi J, Ahmadi M . Expression of Ezrin and Estrogen Receptors During Cervical Carcinogenesis. Reprod Sci. 2016; 24(5):706-712. DOI: 10.1177/1933719116667222. View

18.

Simoncini T, Scorticati C, Mannella P, Fadiel A, Giretti M, Fu X . Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol. 2006; 20(8):1756-71. DOI: 10.1210/me.2005-0259. View

19.

Daniels G . Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture?. Thyroid. 2016; 26(7):872-4. PMC: 4939382. DOI: 10.1089/thy.2016.0244. View

20.

Cant S, Pitcher J . G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton. Mol Biol Cell. 2005; 16(7):3088-99. PMC: 1165394. DOI: 10.1091/mbc.e04-10-0877. View